Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial

  • Clemens Giessen1,
  • Ludwig Fischer von Weikersthal2,
  • Axel Hinke3,
  • Sebastian Stintzing1,
  • Frank Kullmann4,
  • Ursula Vehling-Kaiser5,
  • Julia Mayerle6,
  • Markus Bangerter7,
  • Claudio Denzlinger8,
  • Markus Sieber9,
  • Christian Teschendorf10,
  • Jens Freiberg-Richter11,
  • Christoph Schulz1,
  • Dominik Paul Modest1,
  • Nicolas Moosmann1,
  • Philipp Aubele1 and
  • Volker Heinemann1Email author
BMC Cancer201111:367

DOI: 10.1186/1471-2407-11-367

Received: 28 March 2011

Accepted: 23 August 2011

Published: 23 August 2011

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
28 Mar 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
5 Jul 2011 Reviewed Reviewer Report - Stephen Clarke
29 Jul 2011 Author responded Author comments - Clemens Giessen
Resubmission - Version 3
29 Jul 2011 Submitted Manuscript version 3
20 Aug 2011 Author responded Author comments - Clemens Giessen
Resubmission - Version 4
20 Aug 2011 Submitted Manuscript version 4
Publishing
23 Aug 2011 Editorially accepted
23 Aug 2011 Article published 10.1186/1471-2407-11-367

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Medical Oncology, Klinikum Grosshadern, University of Munich
(2)
MVZ Gesundheitszentrum St. Marien
(3)
WISP GmbH
(4)
Department of Internal Medicine I, Klinikum Weiden
(5)
Oncological Practice
(6)
Department of Medicine, University Hospital Greifswald
(7)
Oncological Practice Augsburg
(8)
Department of Medicine III, Marienhospital
(9)
Department of Medicine II, Gummersbach Hospital
(10)
St.-Josefs-Hospital Dormund-Hörde
(11)
Oncological Practice

Advertisement